Stay updated on NEURO-TTRansform: Eplontersen Efficacy in HATTR Clinical Trial

Sign up to get notified when there's something new on the NEURO-TTRansform: Eplontersen Efficacy in HATTR Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the NEURO-TTRansform: Eplontersen Efficacy in HATTR Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The website has been updated from version 2.14.1 to 2.14.2.
    Difference
    0.3%
    Check dated 2025-02-03T10:53:56.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    The website has been updated from version 2.14.0 to 2.14.1.
    Difference
    0.3%
    Check dated 2025-01-20T01:45:55.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    The type of intervention has been updated from version v2.13.3 to v2.14.0.
    Difference
    1.0%
    Check dated 2025-01-12T21:47:53.000Z thumbnail image
  5. Check
    52 days ago
    Change Detected
    Summary
    The website has posted new results with the latest revision v2.13.3, replacing the previous results submitted under revision v2.13.2.
    Difference
    1%
    Check dated 2024-12-14T23:16:18.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    The website has been updated from version 2.12.2 to 2.13.2, indicating a new release with potential improvements or features.
    Difference
    0.3%
    Check dated 2024-12-07T19:00:49.000Z thumbnail image
  7. Check
    74 days ago
    Change Detected
    Summary
    The website has removed the detailed options for downloading data in various formats and the selection of specific data fields related to clinical studies.
    Difference
    13%
    Check dated 2024-11-23T05:34:50.000Z thumbnail image

Stay in the know with updates to NEURO-TTRansform: Eplontersen Efficacy in HATTR Clinical Trial

Enter your email address, and we'll notify you when there's something new on the NEURO-TTRansform: Eplontersen Efficacy in HATTR Clinical Trial page.